本頁面由Tiger Trade Technology Pte. Ltd.提供服務

NEWAMSTERDAM PHARMA CO NV

21.16
-1.2000-5.37%
盤後22.040.8800+4.16%19:59 EDT
成交量:173.29萬
成交額:3,698.90萬
市值:25.29億
市盈率:-9.87
高:22.62
開:22.32
低:21.08
收:22.36
52周最高:42.21
52周最低:21.08
股本:1.20億
流通股本:9,251.29萬
量比:0.75
換手率:1.87%
股息:- -
股息率:- -
每股收益(TTM):-2.1442
每股收益(LYR):-1.7211
淨資產收益率:-36.81%
總資產收益率:-20.11%
市淨率:4.01
市盈率(LYR):-12.29

資料載入中...

2026/08/25

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/08/14

重要事件披露

Form 8-K - Current report
2026/08/14

重要事件披露

Form 8-K/A - Current report: [Amend]
2026/08/06

超過5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/08/05

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/08/05

重要事件披露

Form 8-K - Current report
2026/07/24

重要事件披露

Form 8-K - Current report
2026/07/22

重要事件披露

Form 8-K - Current report
2026/06/05

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2026/06/04

超過5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/06/03

重要事件披露

Form 8-K - Current report
2026/05/26

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/05/07

重要事件披露

Form 8-K - Current report
2026/05/07

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/05/06

超過5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/04/24

重要事件披露

Form 8-K - Current report
2026/03/11

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/03/06

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/03/05

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/03/02

關聯方擬減持公告

Form 144 - Report of proposed sale of securities